Andere talen ClearPoint Neuro, Inc.

Aandelen

CLPT

US18507C1036

Geavanceerde medische apparatuur & technologie

Beurs gesloten - Nasdaq Andere beurzen 21:00:00 14-03-2025			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
12,80 ^USD	+1,91%		-2,07%	-16,78%

26/02	ClearPoint Neuro, Inc. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2024	CI
26/02	ClearPoint Neuro, Inc., Q4 2024 Earnings Call, Feb 26, 2025

Andere talen

ClearPoint Neuro, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	26/02
ClearPoint Neuro, Inc. Provides Revenue Guidance for the Full Year of 2025	26/02
Clinical Laserthermia Systems AB publishes Year-end report January - December 2024	21/02
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025	17/02
ClearPoint Neuro : to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025	14/02
ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula	13/02
CLS Recaps 2024 and Provides Outlook for 2025-26	14/01
Sector Update: Health Care Stocks Advance Pre-Bell Thursday	14/11
Sector Update: Health Care	14/11
Top Premarket Gainers	14/11
ClearPoint Neuro Says FDA Granted Marketing Authorization for SmartFlow Neuro Cannula	14/11
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain	13/11
ClearPoint Neuro Reports Third Quarter 2024 Results	08/11
ClearPoint Neuro : Material Agreement Form 8 K	08/11
ClearPoint Neuro : Reports Third Quarter 2024 Results Form 8 K	07/11
Earnings Flash (CLPT) CLEARPOINT NEURO Reports Q3 Revenue $8.1M	07/11
ClearPoint Neuro, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	07/11
ClearPoint Neuro, Inc. Reaffirms Revenue Guidance for the Full Year of 2024	07/11
Clinical Laserthermia Systems Advances Towards CE Marking, European Launch of Laser Therapy System	07/11
CLS takes next step towards CE marking in neurosurgery by obtaining ISO certificate according to MDR and completion of study at Skåne University Hospital	07/11
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024	01/11
CLS publishes interim report January - September 2024	31-10-24
ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024	17-10-24
ClearPoint Neuro Repays $10 Million Convertible Note Early	26-08-24
ClearPoint Neuro Announces Early Repayment of $10 Million Note	26-08-24

be493479116de35.jlWyJfX6JoIDh16rVDiCA8DKN_sNPBlkGGktkAAEWx8.zHjkS8yjUe1myRTAbFfAU6alZstfd0sGSwRg8UFeOSjfZIR2vY1qyzLQPQ

Word de lid om toegang te krijgen tot meer nieuws.

Gratis inschrijven

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen ClearPoint Neuro, Inc.

Aandelen

CLPT

US18507C1036

Geavanceerde medische apparatuur & technologie

Andere talen

Filters